NIAID announces new COVID-19 priorities
April 23, 2020 -- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) has released a new strategic plan for accelerating research to diagnose, prevent, and treat COVID-19.
FDA grants emergency authorization for Seegene COVID-19 test
April 22, 2020 -- South Korean firm Seegene has received emergency use authorization from the U.S. Food and Drug Administration (FDA) for its Allplex COVID-19 assay.
U.S. reopening plans shine light on testing supply shortages
April 20, 2020 -- Plans to reopen U.S. state economies in a phased fashion have raised concerns about a lack of capacity for novel coronavirus testing due to a shortage of specimen swabs, personal protective equipment, and other related supplies.  Discuss
Opening the magic box: Lab professionals reveal their value during COVID-19
April 20, 2020 -- The COVID-19 pandemic has brought clinical laboratory professionals out of obscurity and into the limelight. American Association for Clinical Chemistry President-elect David Grenache, PhD, explains why they will stay front and center on the healthcare stage.  Discuss
BioInformatics releases more results from COVID-19 lab tracker survey
April 20, 2020 -- Scientists whose labs have been closed due to the COVID-19 pandemic are spending their time writing and planning future research projects, according to new details released from a survey of lab closures by market research firm BioInformatics.
FDA clears FoundationOne CDx as test for bile duct cancer drug
April 20, 2020 -- Foundation Medicine secured clearance from the U.S. Food and Drug Administration (FDA) for FoundationOne CDx as a companion diagnostic for Incyte's newly approved Pemazyre (pemigatinib) targeted therapy for advanced or metastatic cholangiocarcinoma, also known as bile duct cancer.
ASM asks FDA for better monitoring of COVID-19 serology tests
April 17, 2020 -- The American Society for Microbiology (ASM) has sent a letter to the U.S. Food and Drug Administration (FDA), requesting stronger oversight of the COVID-19 serology tests that are flooding the market during the pandemic.
2 new antibody tests get FDA clearance
April 17, 2020 -- The U.S. Food and Drug Administration (FDA) has issued emergency use authorization for two new tests that detect the presence of antibodies to the virus that causes COVID-19.
CirrusDx to market RT-PCR test for SARS-CoV-2
April 17, 2020 -- CirrusDx will market a real-time reverse transcription polymerase chain reaction (RT-PCR) test that can detect SARS-CoV-2, which causes COVID-19.
FDA clears Mount Sinai’s COVID-19 antibody test
April 17, 2020 -- The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization to Mount Sinai Laboratory in New York City for a blood test that detects the presence of antibodies to the virus that causes COVID-19.